Stay updated on NC318 Safety and Tolerability in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the NC318 Safety and Tolerability in Solid Tumors Clinical Trial page.

Latest updates to the NC318 Safety and Tolerability in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedNo significant changes were observed; the page content and structure appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoChange DetectedResults data has been posted for NC318; a Results tab is now available. The reported outcomes include safety measures (TEAEs) and efficacy endpoints (ORR, DoR, DCR, PFS, OS) plus PK/PD data.SummaryDifference0.5%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedNo significant changes detected.SummaryDifference0.4%

- Check37 days agoChange DetectedMajor update to operating-status notices with a new version tag (v3.2.0); removal of an older medical term and an older version reference. Overall content shifts toward status information rather than the previously listed medical term.SummaryDifference3%

- Check38 days agoChange DetectedUpdated version to v3.1.0 and removed the specific medical term “Head and neck squamous cell carcinoma.”SummaryDifference0.3%

- Check46 days agoChange DetectedNo significant changes detected since there are no additions or deletions to evaluate.SummaryDifference0.4%

Stay in the know with updates to NC318 Safety and Tolerability in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NC318 Safety and Tolerability in Solid Tumors Clinical Trial page.